Active Shortage

NUCYNTA EXTENDED-RELEASE

KNIGHT THERAPEUTICS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NUCYNTA EXTENDED-RELEASE in Canada?

Yes. NUCYNTA EXTENDED-RELEASE 250MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is NUCYNTA EXTENDED-RELEASE not available?

The reason the manufacturer reported: Delay in shipping of the drug.

When will NUCYNTA EXTENDED-RELEASE be available again?

The estimated resolution date (November 11, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products · 1 same form & route

Affected strength250MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NUCYNTA EXTENDED-RELEASE

KNIGHT THERAPEUTICS INC.

50MG · DIN 02415577

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NUCYNTA IR

KNIGHT THERAPEUTICS INC.

75MG · DIN 02378280

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02415615

Strength

250MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

TAPENTADOL

See all TAPENTADOL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-10-27

Active Shortage

Delay in shipping of the drug.

2017-12-06

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from KNIGHT THERAPEUTICS INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AKYNZEO

DIN 02468735

ALOXI

0.5MG · DIN 02381729

ALOXI

0.25MG · DIN 02381710

ANACIN

DIN 02332450

ANTIZOL

1G · DIN 02242980

BIJUVA

DIN 02505223